OneSource Specialty Pharma’s Bangalore facility gets VAI classification from USFDA

10 Jun 2025 Evaluate

OneSource Specialty Pharma’s flagship facility in Bangalore, India, has received a ‘Voluntary Action Indicated’ (VAI) classification from the U.S. Food and Drug Administration (USFDA), confirming its continued compliance.

Following an inspection of the company's flagship facility from March 20 to March 28, 2025, the USFDA issued a Form 483 with four observations. 

OneSource Specialty Pharma is a multimodal specialty pharma CDMO with end-to-end capabilities across technology platforms and therapeutic modalities.


Onesource Specialty Share Price

1741.95 17.00 (0.99%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×